MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WoldeMussie, E.
Right arrow Articles by Beaven, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WoldeMussie, E.
Right arrow Articles by Beaven, M. A.

alpha-Fluoromethylhistidine. Kinetics of uptake and inhibition of histamine synthesis in basophil (2H3) cell cultures

E WoldeMussie and MA Beaven

Labeled histidine was taken up into rat leukemic basophil 2H3 cells by a system with high affinity for histidine and then decarboxylated to form histamine. Uptake was partially inhibited and decarboxylation was completely blocked by alpha-fluoromethylhistidine (alpha-FMH) at concentrations of 10-100 microM. alpha-FMH appeared to be co- transported by a histidine uptake system but the affinity of the system for alpha-FMH was lower than that for histidine (Km 130 and 24 microM, respectively). The drug rapidly penetrated into and became highly localized within the cells. By 60 min the apparent IC50 for inhibition of histamine synthesis in intact cell suspensions was 0.2 microM compared to an IC50 of 1-2 microM alpha-FMH for inhibition of soluble histidine decarboxylase preparations. Turnover of histidine decarboxylase activity in 2H3 cells was rapid (t1/2, 37 min), and biphasic effects were noted after 24-h exposure of 2H3 cells to drug. At low concentrations (greater than 0.1 microM), decarboxylase activity was increased (up to 134 +/- 9% of control values). Higher concentrations of the drug (0.1-10 microM) were inhibitory, and inhibition was related to drug concentration. No detectable decarboxylase activity was observed with 10 microM alpha-FMH after 4 days. Histamine levels increased (up to 232 +/- 2% of control values) or decreased in parallel with decarboxylase activity. Even in cultures devoid of histamine or decarboxylase activity (with 10 microM alpha- FMH) cell division and growth were not affected. Thus the drug appeared to inhibit specifically histamine synthesis without impairing essential cellular metabolic processes. However, kinetics of drug uptake and perturbation of enzyme turnover are additional factors to be considered in the action of alpha-FMH in intact cell systems.

Volume 28, Issue 2, pp. 191-199, 08/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
L C Tetlow and D E Woolley
Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage
Ann Rheum Dis, October 1, 2003; 62(10): 991 - 994.
[Abstract] [Full Text]

Home page
 ScienceHome page
S. Saxena, L. Brandes, A. Becker, K. Simons, F. LaBella, and J. Gerrard
Histamine is an intracellular messenger mediating platelet aggregation
Science, March 24, 1989; 243(4898): 1596 - 1599.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics